Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients. - Wikidata - awgldk - TriplyDB

Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.

Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.

http://www.wikidata.org/entity/Q37728873

about

S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature.

P2860

Q33441277-4138D1D7-0F37-4BB7-86D5-22928042C94B

P2860

Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.

http://www.wikidata.org/entity/Q37728873

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@en

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@nl

type

label

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@en

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@nl

prefLabel

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@en

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@nl

P1433

Q37728873-5EA78E42-BB0A-457B-A470-0191E98FF25B

P1476

Q37728873-74BBAC2B-7196-4EEE-A0B1-53B22E12DAED

P2093

Q37728873-1D1C3681-DE07-4033-8E0D-DF82B20DB5BC

Q37728873-24ABF0A3-650B-4453-B663-9FA4ED7F672B

Q37728873-26E5ADB5-7339-4FBF-ACB7-5039E0FC5380

Q37728873-36975B0B-1949-4DEC-8A9B-F9B97274AC8D

Q37728873-49ABE368-FF60-452F-B89E-E4C0E0213BC9

Q37728873-54D1A513-BFE7-4020-9243-781E4FADF43B

Q37728873-DB5B7714-3A66-4E52-992F-0017C0879139

Q37728873-E4C11C9B-695A-4068-B7BC-43387F3169D7

Q37728873-FB07AC05-811E-4F23-9690-9CDB352CD47D

P2860

Q37728873-0B932B33-A0D4-49E0-89F7-761234F0FF27

Q37728873-0BECFFCF-7236-46AD-8421-93A998D434F9

Q37728873-1523AD90-CEA7-40D3-8C39-3CA79AC7853F

Q37728873-1CD3F139-935B-4683-9975-9697669EB02E

Q37728873-2307FCE7-3F8A-4AF5-AAC6-1E4E8E5AB916

Q37728873-2A8E8DB8-2685-4C28-B06A-25FA938EEE45

Q37728873-367E759A-1E5A-4EC2-89F0-A6F158C0F4A3

Q37728873-4F7898BA-626F-4723-B37D-67515EBBDF03

Q37728873-60199EE8-F14D-4B68-8CAF-D556CF5315F2

Q37728873-604C011C-35E8-466F-A02F-9E16CCEF8CE1

P2888

Q37728873-5B961072-B6EC-4F57-9BE9-F8CA70BFF10D

P304

Q37728873-08E57E44-F3A7-49CA-9F15-19241A78A21B

P31

Q37728873-69151D54-8D93-4A35-AC06-352A23527CE9

P356

Q37728873-AFCFE8DB-F942-4025-9223-58776A571E53

P433

Q37728873-890C42DA-5A95-49BD-B02A-CCE0DE52DC06

P478

Q37728873-4222B5EF-AB82-426C-84D6-3ADFF1A80666

P577

Q37728873-45BF7B1F-DF3C-4AD3-9746-29B41CCD04C1

P5875

Q37728873-0273EEE9-9E8B-409C-A489-B5ABC2C5152F

P698

Q37728873-809502A7-C84F-4F1E-850A-73D61476FEEB

P932

Q37728873-D22CF896-E3E6-48D8-BCEF-8D4AE4DAD29E

P356

P1433

Acta Pharmacologica Sinica

P1476

Pharmacokinetic evaluation of ...... -1 in Chinese cancer patients.

@en

P2093

Hong Zhang

http://www.w3.org/2001/XMLSchema#string

Hong Zhu

http://www.w3.org/2001/XMLSchema#string

Hua-hui Bian

http://www.w3.org/2001/XMLSchema#string

Hui Wang

http://www.w3.org/2001/XMLSchema#string

Ji Wang

http://www.w3.org/2001/XMLSchema#string

Lei Chen

http://www.w3.org/2001/XMLSchema#string

Min-gao Zhu

http://www.w3.org/2001/XMLSchema#string

Wang-yang Pu

http://www.w3.org/2001/XMLSchema#string

Zhi-xiang Zhuang

http://www.w3.org/2001/XMLSchema#string

P2860

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.

Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits

P2888

P304

570-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2012.169

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235441814

http://www.w3.org/2001/XMLSchema#string

P698

23396375

http://www.w3.org/2001/XMLSchema#string

P932

4002783

http://www.w3.org/2001/XMLSchema#string